Blue-grey pigmentation associated with levetiracetam use: a rare adverse effect

dc.contributor.authorYildirim, Harun
dc.contributor.authorCicek, Imren Nur
dc.contributor.authorArslan, Sumeyye
dc.contributor.authorYildirim, Ebru Aydin
dc.date.accessioned2026-08-12T17:11:16Z
dc.date.issued2025
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1007/s10072-025-08532-w
dc.identifier.endpage6135
dc.identifier.issn1590-1874
dc.identifier.issn1590-3478
dc.identifier.issue11
dc.identifier.orcid0009-0001-4064-4287
dc.identifier.orcid0009-0003-1233-0373
dc.identifier.pmid41003969
dc.identifier.scopus2-s2.0-105017392948
dc.identifier.scopusqualityQ1
dc.identifier.startpage6133
dc.identifier.urihttps://doi.org/10.1007/s10072-025-08532-w
dc.identifier.urihttps://hdl.handle.net/11508/51078
dc.identifier.volume46
dc.identifier.wosWOS:001582389500001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer-Verlag Italia Srl
dc.relation.ispartofNeurological Sciences
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleBlue-grey pigmentation associated with levetiracetam use: a rare adverse effect
dc.typeLetter

Dosyalar